StimCell Energetics公司于2025年10月24日被列入OTCQB公司,目的是提高透明度并支持其健康技术商业化。 StimCell Energetics uplisted to OTCQB on Oct. 24, 2025, to improve transparency and support its wellness tech commercialization.

StimCell Energetics Inc. (STME) 于2025年10月24日被列入OTCQB风险市场,符合强化的报告和治理标准。 StimCell Energetics Inc. (STME) uplisted to the OTCQB Venture Market on October 24, 2025, meeting enhanced reporting and governance standards. 此举的目的是提高透明度,增加投资者获得投资的机会,并支持其eBalance-健康技术的商业化,该技术以蜂窝能源、老龄化、胰岛素敏感性和肾功能为目标。 The move aims to boost transparency, investor access, and support the commercialization of its eBalance® wellness technology, which targets cellular energy, aging, insulin sensitivity, and kidney function. 该公司强调正在进行的研发和遵守情况,领导强调这一里程碑是迈向长期价值的一个步骤。 The company emphasized ongoing R&D and compliance, with leadership highlighting the milestone as a step toward long-term value. 敦促投资者审查证交会提交的风险披露文件。 Investors are urged to review SEC filings for risk disclosures.